Fig. 2.
a Schematic view of subcutaneous depot and sustained drug release. Inset shows diffusion of active drug to the adjacent capillaries. b Pharmacokinetic properties and c concentration-time curve of lanreotide depot after a single 120-mg injection in healthy volunteers [5, 6]. C 28 mean serum concentration 28 days after injection, C max peak serum concentration, T max time to reach C max, t 1/2 apparent terminal elimination half-life